UBS Group
PMI

UBS Group’s Picard Medical PMI Stock Holding History

UBS Group’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83K Sell
2,725
-30,139
-92% -$43.7K ﹤0.01% 9194
2025
Q4 		$57.5K Buy
32,864
+27,381
+499% +$129K ﹤0.01% 7157
2025
Q3 		$46.6K Buy
+5,483
New +$38.6K ﹤0.01% 7615

Other funds holding PMI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group's PMI Position: Q1 2026 in Review

UBS Group reduced its Picard Medical (PMI) stake by 92% in Q1 2026, selling an estimated $43.7K and leaving 2,725 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #9194.

UBS Group first reported a position in PMI in Q3 2025 and has held it in 3 quarters since. The position peaked at $57.5K in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • UBS Group held 2,725 shares of Picard Medical worth $2.83K as of Q1 2026.
  • UBS Group sold 30,139 Picard Medical shares in Q1 2026, an estimated $43.7K.
  • Picard Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9194 holding.
  • UBS Group first reported a position in Picard Medical in Q3 2025 and has held it in 3 quarters since.
  • UBS Group's Picard Medical position peaked at $57.5K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.